$HQY
HEALTHEQUITY, INC.

2020 Q4 Form 10-Q Financial Statement

#000142833620000031 Filed on December 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019 Q3
Revenue $179.4M $157.1M $86.62M
YoY Change 14.15% 122.88% 21.89%
Cost Of Revenue $74.79M $61.08M $28.18M
YoY Change 22.44% 147.52% 15.07%
Gross Profit $104.6M $96.04M $58.44M
YoY Change 8.87% 109.61% 25.48%
Gross Profit Margin 58.3% 61.12% 67.46%
Selling, General & Admin $34.98M $31.88M $17.65M
YoY Change 9.73% 91.3% 16.63%
% of Gross Profit 33.45% 33.19% 30.21%
Research & Development $30.76M $23.51M $11.65M
YoY Change 30.82% 170.93% 38.66%
% of Gross Profit 29.42% 24.48% 19.93%
Depreciation & Amortization $4.000M $3.600M $1.000M
YoY Change 11.11% 300.0% 25.0%
% of Gross Profit 3.83% 3.75% 1.71%
Operating Expenses $93.06M $86.11M $33.58M
YoY Change 8.06% 220.95% 34.24%
Operating Profit $11.50M $9.922M $24.86M
YoY Change 15.92% -47.74% 15.31%
Interest Expense $6.952M $10.23M $67.00K
YoY Change -32.01% 14936.76%
% of Operating Profit 60.44% 103.05% 0.27%
Other Income/Expense, Net -$7.373M -$41.17M -$1.128M
YoY Change -82.09% 2547.85% 1404.0%
Pretax Income $4.129M -$31.25M $23.74M
YoY Change -113.21% -279.29% 10.46%
Income Tax $2.340M -$9.918M $4.370M
% Of Pretax Income 56.67% 18.41%
Net Earnings $1.789M -$21.33M $19.37M
YoY Change -108.39% -236.01% -13.99%
Net Earnings / Revenue 1.0% -13.58% 22.36%
Basic Earnings Per Share $0.02 -$0.30 $0.30
Diluted Earnings Per Share $0.02 -$0.30 $0.30
COMMON SHARES
Basic Shares Outstanding 76.70M shares 70.52M shares 64.22M shares
Diluted Shares Outstanding 77.85M shares 70.52M shares 65.58M shares

Balance Sheet

Concept 2020 Q4 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $299.4M $174.6M $815.2M
YoY Change 71.48% -47.14% 169.13%
Cash & Equivalents $299.4M $174.6M $815.2M
Short-Term Investments
Other Short-Term Assets $32.38M $29.12M $11.00M
YoY Change 11.21% 225.24% -6.21%
Inventory
Prepaid Expenses
Receivables $64.29M $66.65M $27.36M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $396.0M $270.3M $853.5M
YoY Change 46.5% -25.7% 151.25%
LONG-TERM ASSETS
Property, Plant & Equipment $31.77M $35.20M $9.873M
YoY Change -9.73% 302.6% 11.32%
Goodwill $1.327B $1.335B $4.651M
YoY Change -0.63% 28607.53% 0.0%
Intangibles $776.3M $796.2M $88.77M
YoY Change -2.5% 886.29% 7.89%
Long-Term Investments $200.0K $209.0K
YoY Change 0.0% 109.0%
Other Assets $34.02M $34.47M $22.31M
YoY Change -1.31% 88.36% 23.58%
Total Long-Term Assets $2.261B $2.290B $244.8M
YoY Change -1.24% 1910.91% 113.1%
TOTAL ASSETS
Total Short-Term Assets $396.0M $270.3M $853.5M
Total Long-Term Assets $2.261B $2.290B $244.8M
Total Assets $2.657B $2.560B $1.098B
YoY Change 3.8% 435.89% 141.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.746M $7.966M $2.740M
YoY Change -15.32% 432.84% 54.89%
Accrued Expenses $33.38M $54.31M $19.39M
YoY Change -38.53% 809.33% 247.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $62.50M $31.25M
YoY Change 100.0%
Total Short-Term Liabilities $151.4M $141.9M $37.14M
YoY Change 6.7% 715.29% 117.59%
LONG-TERM LIABILITIES
Long-Term Debt $938.6M $1.196B $0.00
YoY Change -21.53%
Other Long-Term Liabilities $11.43M $2.590M $735.0K
YoY Change 341.27% -8.67% -72.71%
Total Long-Term Liabilities $1.151B $1.199B $735.0K
YoY Change -4.0% 34175.26% -85.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $151.4M $141.9M $37.14M
Total Long-Term Liabilities $1.151B $1.199B $735.0K
Total Liabilities $1.302B $1.542B $81.31M
YoY Change -15.57% 7279.82% 269.87%
SHAREHOLDERS EQUITY
Retained Earnings $215.0M $211.7M $233.0M
YoY Change 1.55% 33.37% 62.91%
Common Stock $8.000K $7.000K $7.000K
YoY Change 14.29% 16.67% 16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.355B $1.018B $1.017B
YoY Change
Total Liabilities & Shareholders Equity $2.657B $2.560B $1.098B
YoY Change 3.8% 435.89% 141.6%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $1.789M -$21.33M $19.37M
YoY Change -108.39% -236.01% -13.99%
Depreciation, Depletion And Amortization $4.000M $3.600M $1.000M
YoY Change 11.11% 300.0% 25.0%
Cash From Operating Activities $52.00M $17.30M $31.50M
YoY Change 200.58% -38.65% 5.35%
INVESTING ACTIVITIES
Capital Expenditures -$21.00M -$16.80M -$6.800M
YoY Change 25.0% 366.67% 30.77%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.630B $0.00
YoY Change -100.0% 814950.0% -100.0%
Cash From Investing Activities -$21.00M -$1.647B -$6.900M
YoY Change -98.72% 43236.84% 27.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -600.0K 989.0M 461.2M
YoY Change -100.06% 35221.43% 5456.63%
NET CHANGE
Cash From Operating Activities 52.00M 17.30M 31.50M
Cash From Investing Activities -21.00M -1.647B -6.900M
Cash From Financing Activities -600.0K 989.0M 461.2M
Net Change In Cash 30.40M -640.5M 485.8M
YoY Change -104.75% -2454.78% 1381.1%
FREE CASH FLOW
Cash From Operating Activities $52.00M $17.30M $31.50M
Capital Expenditures -$21.00M -$16.80M -$6.800M
Free Cash Flow $73.00M $34.10M $38.30M
YoY Change 114.08% 7.23% 9.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001428336
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36568
dei Entity Registrant Name
EntityRegistrantName
HEALTHEQUITY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2383166
dei Entity Address Address Line1
EntityAddressAddressLine1
15 West Scenic Pointe Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Address City Or Town
EntityAddressCityOrTown
Draper,
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84020
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
727-1000
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
HQY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76990646 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
299356000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191726000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3458000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1216000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
64291000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70863000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32383000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34711000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
396030000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
297300000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31774000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33486000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
92314000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
83178000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
776311000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
783279000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1326793000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
1332631000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
21000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34019000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35089000 USD
CY2020Q4 us-gaap Assets
Assets
2657262000 USD
CY2020Q1 us-gaap Assets
Assets
2564981000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6746000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3980000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34839000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50121000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33380000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46372000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
62500000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
39063000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13894000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12401000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
151359000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
151937000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
938558000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1181615000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
76666000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
68017000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11429000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2625000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
123993000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
130492000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1150646000 USD
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1382749000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1302005000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
1534686000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76951000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76951000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71051000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71051000 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
7000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1140268000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
818774000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
214981000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
211514000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1355257000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030295000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2657262000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2564981000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
179351000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157118000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
545401000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
330793000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
74793000 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
61083000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
230985000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
118565000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
104558000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
96035000 USD
us-gaap Gross Profit
GrossProfit
314416000 USD
us-gaap Gross Profit
GrossProfit
212228000 USD
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12880000 USD
CY2019Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12654000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
36502000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30015000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30758000 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23511000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
92490000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46061000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22099000 USD
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19222000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61590000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37193000 USD
CY2020Q4 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
19126000 USD
CY2019Q4 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
13051000 USD
hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
56905000 USD
hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
16036000 USD
CY2020Q4 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
8193000 USD
CY2019Q4 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
17675000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
31328000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
20459000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
93056000 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
86113000 USD
us-gaap Operating Expenses
OperatingExpenses
278815000 USD
us-gaap Operating Expenses
OperatingExpenses
149764000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
11502000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
9922000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
35601000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
62464000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
6952000 USD
CY2019Q4 us-gaap Interest Expense
InterestExpense
10225000 USD
us-gaap Interest Expense
InterestExpense
28110000 USD
us-gaap Interest Expense
InterestExpense
10355000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-421000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30949000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2009000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8347000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7373000 USD
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-41174000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30119000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18702000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4129000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31252000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5482000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
43762000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2340000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9918000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2015000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3908000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1789000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1789000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21334000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-21334000 USD
us-gaap Net Income Loss
NetIncomeLoss
3467000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3467000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39854000 USD
us-gaap Net Income Loss
NetIncomeLoss
39854000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76701000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70524000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73358000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65727000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77845000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70524000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74665000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67150000 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1340336000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1017031000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030295000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
477079000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1355257000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1017761000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1355257000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1017761000 USD
us-gaap Net Income Loss
NetIncomeLoss
3467000 USD
us-gaap Net Income Loss
NetIncomeLoss
39854000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
85485000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28791000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
30313000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
31194000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3818000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1138000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
27570000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1727000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-139000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-973000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
690000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8063000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1901000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3309000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4863000 USD
hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-8344000 USD
hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-3340000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15251000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8012000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7936000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14179000 USD
hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-8361000 USD
hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-2859000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
8712000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-50000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
120717000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74070000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11388000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5180000 USD
us-gaap Payments For Software
PaymentsForSoftware
37242000 USD
us-gaap Payments For Software
PaymentsForSoftware
17232000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
28100000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9070000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
53845000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1630066000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76730000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1715393000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
286779000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
458495000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
223438000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
4189000 USD
hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
230928000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4491000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7342000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1250000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
30504000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
63643000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1454405000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107630000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-186918000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191726000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
361475000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299356000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174557000 USD
us-gaap Interest Paid Net
InterestPaidNet
22849000 USD
us-gaap Interest Paid Net
InterestPaidNet
249000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1053000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9127000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
167000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
168000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
5838000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0 USD
hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
89000 USD
hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
21000 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
3776000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1789000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-21334000 USD
us-gaap Net Income Loss
NetIncomeLoss
3467000 USD
us-gaap Net Income Loss
NetIncomeLoss
39854000 USD
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70524000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76701000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70524000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73358000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65727000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76701000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73358000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65727000 shares
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1144000 shares
CY2019Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1307000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1423000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77845000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70524000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74665000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67150000 shares
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000.0 shares
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
us-gaap Depreciation
Depreciation
5400000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58907000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49243000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27133000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15757000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31774000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33486000 USD
CY2020Q4 us-gaap Depreciation
Depreciation
4000000.0 USD
CY2019Q4 us-gaap Depreciation
Depreciation
3600000 USD
us-gaap Depreciation
Depreciation
12000000.0 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7000000.0 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3700000 USD
hqy Contract With Customer Recognition Term Interchange Arrangement
ContractWithCustomerRecognitionTermInterchangeArrangement
P10Y
CY2020Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2200000 USD
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
3777000 USD
CY2019Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
3354000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
12297000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
5515000 USD
CY2020Q4 us-gaap Sublease Income
SubleaseIncome
450000 USD
CY2019Q4 us-gaap Sublease Income
SubleaseIncome
249000 USD
us-gaap Sublease Income
SubleaseIncome
1349000 USD
us-gaap Sublease Income
SubleaseIncome
249000 USD
CY2020Q4 us-gaap Lease Cost
LeaseCost
3327000 USD
CY2019Q4 us-gaap Lease Cost
LeaseCost
3105000 USD
us-gaap Lease Cost
LeaseCost
10948000 USD
us-gaap Lease Cost
LeaseCost
5266000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
9739000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
4575000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
17480000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
34394000 USD
CY2020Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
174000 USD
CY2019Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2046000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
850000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
5273000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
0 USD
CY2019Q4 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
285000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
0 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
27570000 USD
CY2020Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
13000 USD
CY2019Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
32932000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
79000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
40712000 USD
CY2020Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
582000 USD
CY2019Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
348000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2780000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
478000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-421000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30949000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2009000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8347000 USD
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
31100000 USD
CY2019Q4 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
6200000 USD
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
13800000 USD
CY2020Q4 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
10500000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
947971000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
879597000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
172276000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
98851000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
775695000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
780746000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
776311000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
783279000 USD
CY2020Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0218
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25300000 USD
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15700000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
73500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23600000 USD
CY2020Q4 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
7000000.0 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
5800000 USD
CY2018Q3 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2018Q2 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000.0 USD
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.567
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.368
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.317
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.089
CY2020Q4 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.060
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.096
CY2019Q4 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.011
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.087
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10000000.0 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9400000 USD
CY2020Q1 hqy Unrecognized Tax Benefit Net
UnrecognizedTaxBenefitNet
500000 USD
CY2020Q4 hqy Unrecognized Tax Benefit Net
UnrecognizedTaxBenefitNet
500000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9200000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1018800000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
17700000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1001100000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
17700000 USD
CY2020Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0165
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
15600000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
62500000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
70300000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
101600000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
768800000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1018800000 USD
hqy Debt Instrument Covenant Description Acquisition Threshold For Maximum Total Net Leverage Ratio
DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio
100000000.0 USD
CY2020Q4 hqy Debt Instrument Covenant Description Interest Coverage Ratio
DebtInstrumentCovenantDescriptionInterestCoverageRatio
3.00
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11479000 USD
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23156000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30313000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36774000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2040000 shares
CY2020Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
0.10
CY2020Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.35
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
74009000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
16000 shares
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Granted
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted
66.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
66.06
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
183000 shares
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised
0.10
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised
44.53
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10000 shares
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited
25.45
hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited
44.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
38.02
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1863000 shares
CY2020Q4 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
1.25
CY2020Q4 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.23
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42046000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1863000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
31.23
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
42046000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1584000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
26.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
41025000 USD

Files In Submission

Name View Source Status
0001428336-20-000031-index-headers.html Edgar Link pending
0001428336-20-000031-index.html Edgar Link pending
0001428336-20-000031.txt Edgar Link pending
0001428336-20-000031-xbrl.zip Edgar Link pending
exhibit311-ceo302xfy21.htm Edgar Link pending
exhibit312-cfo302xfy21.htm Edgar Link pending
exhibit321-ceo906xfy21.htm Edgar Link pending
exhibit322-cfo906xfy21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hqy-20201031.htm Edgar Link pending
hqy-20201031.xsd Edgar Link pending
hqy-20201031_cal.xml Edgar Link unprocessable
hqy-20201031_def.xml Edgar Link unprocessable
hqy-20201031_htm.xml Edgar Link completed
hqy-20201031_lab.xml Edgar Link unprocessable
hqy-20201031_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending